Abstract
AbstractNew microbial metabolite screening currently requires an interdisciplinary team consisting of microbial ecologists, geneticists, molecular biologists, biochemists, microbial physiologists, fermentation technologists and chemists. The increasing difficulty in discovering new compounds of clinical potential can only be overcome by maximising the input of the above disciplines. Possible strategies for constructing a genetically diverse ‘bank’ of microorganisms, including naturally occurring and genetically manipulated strains, are reviewed. Also, the design of environmental conditions optimal for the over‐production of metabolites and the types of screens that are selective for compounds of potential utility are discussed. The value of target‐selective screen techniques is illustrated with experiences gained in the search for new β‐lactams.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
